home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Software Vault: The Diamond Collection
/
The Diamond Collection (Software Vault)(Digital Impact).ISO
/
cdr16
/
med9505a.zip
/
M9550146.TXT
< prev
next >
Wrap
Text File
|
1995-03-04
|
2KB
|
29 lines
Document 0146
DOCN M9550146
TI Clinical and immunological markers in Kenyan pulmonary tuberculosis
patients with and without HIV-1.
DT 9505
AU Kivihya-Ndugga LE; Ochola JJ; Otieno G; Muthami LN; Gathua S; Diseases
Research Unit, Kenya Medical Research Institute,; Nairobi.
SO East Afr Med J. 1994 Jun;71(6):373-5. Unique Identifier : AIDSLINE
MED/95136904
AB Amongst newly diagnosed pulmonary tuberculosis patients, 44% were
co-infected with human immunodeficiency virus (HIV). Pulmonary
tuberculosis patients with HIV-1 presented more frequently with
lymphadenopathy and diarrhoea than those without HIV-1. Peripheral blood
CD4+ counts were significantly lower in patients with pulmonary
tuberculosis with HIV-1 than those with pulmonary tuberculosis alone, P
= 0.0292. CD4+ lymphocyte counts, lymphadenopathy and BCG scar could
serve as indicators of HIV-1 infection in pulmonary tuberculosis (PTB)
patients.
DE Adult AIDS-Related Opportunistic Infections/*BLOOD/EPIDEMIOLOGY/
IMMUNOLOGY Biological Markers/BLOOD BCG Vaccine Comorbidity
Comparative Study CD4 Lymphocyte Count Female Human *HIV
Seronegativity *HIV-1 Kenya/EPIDEMIOLOGY Male Support, Non-U.S.
Gov't Tuberculosis, Pulmonary/*BLOOD/EPIDEMIOLOGY/IMMUNOLOGY JOURNAL
ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).